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Histopathological effects of S. xylosus peptidoglycan in
comparison to E. coli lipopolysaccharide in the
urinary tract of mice
Harith Jabbar Fahad AL-MATHKHURY, May Talib FLAIH, Hiba Khalil TAWFIQ

Aim: The present work, among other previous studies done in our lab, aimed to highlight the histopathological effect of
S. xylosus peptidoglycan in comparison to LPS of E. coli.
Materials and methods: One hundred and fifty urine specimens were collected from urinary tract infection patients
visiting Baghdad hospitals. The histopathological effects of S. xylosus S24 peptidoglycan was studied in the urinary tract
of female mice by injecting 5 animal groups at the following concentrations: 1000, 2000, 3000, 4000, and 5000 µg/mL.
Another 5 groups were injected with 10, 25, 50, 75, and 100 ng/mL of E. coli (serotype 0128:B12) LPS.
Results: Ten isolates were confirmed to be Staphylococcus xylosus. Histopathological study showed different pathological
changes caused by LPS and peptidoglycan, including shrinkage of glomeruli, congestion of blood vessels, and infiltration
of inflammatory cells in the kidney, whereas dekeratinization and edematous dehydration of the epithelium were seen in
the urinary bladder. Based on a comparison between histopathological changes caused by LPS and peptidoglycan, LPS
induced changes of significantly higher severity than peptidoglycan.
Conclusion: Peptidoglycan of S. xylosus had remarkable histopathological effects on the renal system of mice in a dosedependent manner. Nevertheless, these effects had less intensity than the effects of LPS of E. coli.
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Introduction
Many bacterial components warn the immune
system about the presence of bacterial invasion;
therefore, they are considered key players in such
invasion (1). Evidently, lipopolysaccharide (LPS) is
not the only etiological factor responsible for septic
shock syndrome (2). Peptidoglycan of gram-positive
bacteria has the ability to activate leukocytes and
trigger the release of proinflammatory cytokines,
causing a systemic inflammatory response (3).
Infections caused by coagulase negative
staphylococci have received much attention (4).
Although S. xylosus is regularly isolated from food
products, the environment, and human skin (5),

Carrillo et al. (6) stated that S. xylosus is a newly
emerging nosocomial pathogen. Moreover, this
bacterium was the agent responsible for some serious
infections like endocarditis, toxic shock syndrome,
dermatitis, bacteremia, and urinary tract infection
(UTI) (7). The capability of S. xylosus to initiate
an infection could be attributed to its capacity to
form a biofilm on different surfaces in addition to
other virulence factors (8). Unlike S. saprophyticus
less attention has been paid toward S. xylosus as
a causative agent of UTI since its incidence was
around 1%. However, in local previous studies this
bacterium was isolated in a relatively high percentage
of Iraqi patients who presented with UTI (9,10).
Furthermore, S. xylosus was able to colonize the
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Due to this increasing isolation percentage in
Iraqi patients, we planned to investigate some of
the potential pathological aspects of this species.
Therefore, the present work, among other previous
studies done in our lab, aimed to highlight the
histopathological effect of S. xylosus peptidoglycan in
comparison to LPS of E. coli.

Number of resistant isolaties

kidney and the urinary bladder of mice when injected
intraurethrally (11).
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Figure 1. Antibiotic susceptibility of S. xylosus isolated from
UTI patients.

Materials and methods
Specimen collection
One hundred and fifty mid-stream urine specimens
were collected in sterile containers from patients
who presented with UTI visiting Al-Yarmouk, AlZa’frania, Madinat Altib, and Al-Karama hospitals in
Baghdad.
Isolation and identification
All specimens were cultured on blood agar and
incubated at 37 °C for 24 h. Thereafter, the grown
colonies were transferred onto mannitol salt agar.
Mannitol fermenter colonies were picked and
transferred onto nutrient agar for a purity check and
morphological study. Identification was performed
according to Kloos and Schliefer (12) and Holt et
al. (13). The biochemical tests were carried out in
accordance with Frobes et al. (14). The API Staph
system was employed to confirm the identification.
Antibiotic susceptibility test
All S. xylosus isolates were tested for their
susceptibility toward amoxicillin (25 µg), cephalothin
(30 µg), ciprofloxacin (5 µg), erythromycin (15 µg),
and gentamicin (10 µg), following the procedure
described by Bauer et al. (15). For quality control
measures S. aureus ATCC 6538P standard strain was
tested as well.

Peptidoglycan extraction
The peptidoglycan of S. xylosus S24 was extracted
following the procedure of De-Jonge et al. (16).
Briefly, 1 L of culture was quickly chilled in an ice/
ethanol bath until the temperature dropped below 10
°C. The cells were harvested by centrifugation for 10
min at 16,000 × g (4 °C) and subsequently transferred
into 4% boiling sodium dodecyl sulfate (SDS). The
cells were boiled for 0.5 h and the cell walls were then
concentrated by centrifugation for 10 min at 30,000
× g. The walls were washed with water until no more
SDS could be detected. Cell walls were broken with
glass beads (0.2 mm) by vortexing at maximal speed
at 4 °C for 15 min. The suspension was centrifuged at
2000 × g, and, after removal of the supernatant, the
pellet was treated with glass beads as described above.
The collected broken walls were centrifuged at 40,000
× g for 15 min, and the pellet was resuspended at 37
°C in 100 mM Tris-HCl (pH 7.5) with the addition
of 20 mM MgCl2, DNase, and RNase. DNase and
RNase (Sigma) were added at a concentration of 10
μg/mL and 50 μg/mL, respectively, and the mixture
was incubated for 2 h at 37 °C. The incubation was
prolonged for another 2 h. Thereafter, the suspension
was treated with trypsin (Sigma) in the presence

Table. Protein and carbohydrates concentrations in crude cell walls and peptidoglycan of S. xylosus.
Extract

Protein concentration (µg/mL)

Carbohydrate concentration (µg/mL)

Crude cell wall

197.5

16.600

Peptidoglycan

54.4

40.00
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Figure 2. Gel electrophoresis of crude cell wall (A) and
peptidoglycan (B) of S. xylosus.

of 10 mM CaCl2 for 18 h. Autolytic enzymes were
inactivated by boiling for 15 min in 1% SDS. The
walls were collected by centrifugation as described
above and washed twice with water, once with 8 M
LiCl, once with 100 mM EDTA, and then twice with
water before being washed with acetone. Finally,
the broken walls were resuspended in aliquots of
sterilized distilled water.
Protein concentration was estimated during
and after purification according to the method
described by Lowry et al. (17). Carbohydrates were
assayed following the method reported by Dubois
et al. (18). Peptidoglycan purity was confirmed
by polyacrylamide gel electrophoresis under
nondenaturizing conditions.

Figure 3. Cross section in mice kidney (A) and urinary bladder
(B) shows the normal texture of them. G = glomerulus,
T = tubules, E = epithelial layer, F = fat layer, M =
mucosa layer. 400×. H&E.

In vivo study

Groups 6–10 were injected with 20 µL of E. coli
serotype 0128: B12 LPS (purchased from Sigma,
USA) at concentrations of 10, 25, 50, 75, and 100 ng/
mL, respectively. Group 11 was injected with normal
saline and, consequently, considered the control
group.

Animals

Injection protocol

Female white mice (Mus musculus) aged 7–8
weeks and weighing 21–24 g were obtained from
the National Center for Drugs Supervision and
Researches, Baghdad, Iraq. The mice were housed in
plastic cages and fed ad libitum with a conventional
diet. The animals were divided into 11 groups and
injected as follows:

First of all the bladder was emptied of urine by
pressing on the abdominal area. The urethra and
surrounding area were sterilized with 75% ethanol and
then a polyethylene tube (0.6 mm in diameter) was
introduced into the urinary bladder via the urethra;
the inoculums (20 µL) were injected by the aid of
this catheter. Thereafter, the catheter was withdrawn
immediately and the animals were returned to their
cages with their lower end directed upward to avoid
effusion of the inoculum outside (19).

Groups 1–5 were injected with 20 µL of
peptidoglycan extract at concentrations of 1000,
2000, 3000, 4000, and 5000 µg/mL, respectively.
1280
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Figure 4. Cross section in mice kidney injected with a) 3000 µg/mL, b) 4000 µg/mL, and c) 5000 µg/mL of partially purified
peptidoglycan of S. xylosus shows shrinkage of glomerulus (thin black arrow), hemostasis and congestion inside the
blood vessel (thick black arrow), and infiltration of inflammatory cells (white arrow). 400×. H&E.

All animals were kept in their cages without water
for 24 h. After 4 days of injection they were sacrificed
and the left kidneys and bladders were aseptically
removed for histopathological study according to
Bancroft and Steven (20).
Results and discussion
Isolation and identification
Out of 150 bacterial isolates, 61 (40.6%) isolates
were identified as staphylococci. Forty-eight (78.7%)
isolates were coagulase negative staphylococci.
While 13 (21.3%) isolates were positive coagulase
staphylococci, 10 (16.4%) isolates were identified as
S. xylosus.

Antibiotic susceptibility
The results revealed that the 10 S. xylosus isolates
varied in their antibiotic susceptibility. Erythromycin
was the least effective antibiotic, whereas ciprofloxacin
exhibited the highest efficacy (Figure 1). Moreover,
S. xylosus S4 developed multidrug resistance toward
all antibiotics under investigation; therefore, it was
chosen for further experiments.
Al-Mathkhury et al. (10) confirmed that S. xylosus
isolated from Iraqi patients who presented with UTI
showed high sensitivity toward ciprofloxacin and
high resistance toward erythromycin. Barger-Bächi
(21) reported that CoNS developed resistance toward
macrolides due to the erm gene.
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In vivo study
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Peptidoglycan
Histopathological sections of the control group
showed normal urinary tract texture (Figure 3). The
results also revealed that injecting mice with 1000
and 2000 µg/mL of partially purified peptidoglycan of
S. xylosus caused no pathological changes in kidney
tissues, while injection with 3000 µg/mL caused mild
histopathological changes represented by shrinkage
of glomeruli (Figure 4a).
Furthermore, 4000 µg/mL of S. xylosus
peptidoglycan caused hemostasis and congestion of
the endothelial layer of blood vessels (Figure 4b).
Moreover, severe changes were seen in sections of
kidneys treated with 5000 µg/mL; in addition to
previous changes, infiltration of inflammatory cells
was also noted (Figure 4c).
Regarding the urinary bladder, injecting the
mice with 1000, 2000, and 3000 µg/mL of partially
purified peptidoglycan of S. xylosus did not lead to
any pathological changes. The concentration 4000
µg/mL caused marked histopathological changes
such as hydropic degeneration of epithelial tissue and
loss of the fat layer (Figure 5a).

Figure 5. Cross section in mice urinary bladder injected
with a) 4000 µg/mL and b) 5000 µg/mL of partially
purified peptidoglycan of S. xylosus shows hydropic
degeneration (black arrow) and absence of fat layer
(white arrow) and increased space around the epithelial
cells’ nuclei (small black arrows). 400×. H&E.

As shown in the Table, at the end of the extraction
process the protein concentration decreased while
the carbohydrates concentration increased.
Figure 2 illustrates that the gel electrophoresis
bands were reduced from 8 (crude cell walls) to 6
bands (peptidoglycan). These 2 results confirmed the
efficacy of the extraction procedure (22).
Umenda et al. (23) reported that gel electrophoresis
revealed 10 protein bands after extraction with SDS
and proteolytic enzymes. Flaih et al. (24) stated that
extracted Streptococcus pneumoniae peptidoglycan
showed 4 bands while its crude cell wall developed
6 bands.
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Additionally, Figure 5b shows histopathological
changes due to injection of 5000 µg/mL of partially
purified peptidoglycan of S. xylosus represented
by hydropic degeneration of epithelial tissue and
disappearance of the fat layer in addition to increased
space around the epithelial layer nuclei.
Such histopathological changes could be
attributed to immunological effects triggered by the
interaction the peptidoglycan with receptors found
on mononuclear cell surfaces and eventually lead
to TNF-α and IL-1 release, and on macrophages to
liberation of TNF-α (25). Moreover, it can stimulate
polymorphonuclear leukocytes to induce autolytic
enzymes and activation of mast cells to liberate
histamine in addition to increasing blood vessel
permeability. By means of its high molecular weight,
peptidoglycan can induce acute and chronic immune
responses (26).
In a previous study (10), similar changes were
seen in mice injected with live cells of S. xylosus
represented by glomerulus shrinkage, hemorrhage,
congestion, vacuolation of blood vessels, and
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Figure 6. Cross section in mouse kidney injected with a) 50 ng/mL, b, c, d, and e) 100 ng/mL of E. coli (serotype 0128:B12)
LPS shows infiltration of inflammatory cells (white arrow), shrinkage of glomerulus (G), hemorrhage (doubleheaded arrow), obstruction of tubules (thin black arrow), hemostasis inside blood vessel (H) and segmental corpuscle
degeneration, hemostasis (black arrow), and vacuolation in the blood vessel (white triangle). 400×. H&E.

infiltration of inflammatory cells in kidney tissue.
The urinary bladder suffered from hydropic
degeneration, dekeratinization, and infiltration of
inflammatory cells.

LPS of E. coli (serotype 0128:B12)
When the mice were challenged with 10 and 25 ng/
mL of E. coli (serotype 0128:B12) LPS, kidney and
1283
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degeneration in the epithelial layer, as shown in
Figure 7a.
The urinary bladder tissue of mice injected with
100 ng/mL of LPS developed serious pathological
changes such as complete loss of the fat layer, hydropic
degeneration in the epithelial layer, expansion of the
subepithelial layer, and infiltration of inflammatory
cells (Figure 7b).
All these changes in the tissues of the kidney and
urinary bladder caused by LPS could be assigned
to the immunopathological role of this molecule,
which leads to activation of the coagulation pathway
and aggregation of leukocytes, consequently to
destruction of the endothelial layer, and eventually
to organ failure. Nevertheless, the increase in LPS
concentration causes a corresponding increase in
symptoms and signs of inflammation (27,28).
Regarding all these findings, we can see clearly
that the pathological effects are similar for S. xylosus
peptidoglycan and LPS of E. coli (serotype 0128:B12)
but they differ in terms of intensity.

Figure 7. Cross section in mouse urinary bladder injected with
a) 75 ng/mL and b) 100 ng/mL of E. coli (serotype
0128:B12) LPS shows partial loss of the fat layer (black
arrow) and hydropic degeneration (white arrow),
increase in thickness of the subepithelial layer (doubleheaded arrow), and infiltration of inflammatory cells
(triangles) 400×. H&E.

urinary bladder cross sections shows no pathological
signs. However, mild infiltration of inflammatory
cells and shrinkage of glomeruli were noted in
kidney tissues after injection of 50 and 75 ng/mL of
LPS (Figure 6a).
More severe histopathological changes such as
hemorrhage (Figure 6b), infiltration of inflammatory
cells, obstruction of tubules (Figure 6c), segmental
corpuscle degeneration, hemostasis (Figure 6d), and
vacuolation (Figure 6e) of the blood vessels were seen
in the kidneys of mice injected with 100 ng/mL of E.
coli (serotype 0128:B12) LPS.
On the other hand, 10, 25, and 50 ng/mL of LPS
had no effect on the urinary bladder, while 75 ng/
mL caused partial loss of the fat layer and hydropic
1284

Weidemann et al. (29) found that peptidoglycan,
like LPS, was able to induce IL-6 and IL-1 production
by mononuclear cells. However, dose-response
experiments revealed that at least 3000 ng of
peptidoglycan per mL was necessary for induction,
whereas the optimal LPS concentration was 1 ng/mL.
LPS has been reported to increase leptin mRNA
expression, as well as circulating leptin levels
(30). Recently, MacKenzie et al. (31) stated that
peptidoglycans derived from gram-negative bacteria
(E. coli 0111:B4 and K12) are potent inducers of IL1β and IL-6 gene expression and were equal to, or
more potent than, crude LPS. On the other hand,
peptidoglycans of gram-positive bacteria, DNA,
RNA, and lipoteichoic acid were weak stimulators,
while lipid A, lipoprotein, and ultrapure LPS were
nonstimulatory.
In conclusion, peptidoglycan of S. xylosus
demonstrates noteworthy pathological effects on the
renal system of mice in a dose dependent manner.
However, these effects have less intensity than the
effects of LPS of E. coli (serotype 0128:B12). Much
work is needed to shed light on these differences
with respect to cytokine production, responses to the
involved receptors, and above all their inflammatory
response in vivo or ex vivo.
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